Schistosomiasis japonica: Clinical Trials

2 trials for Schistosomiasis japonica, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Schistosomiasis japonica: new trials by email Literature Review of Schistosomiasis japonica trials Research Report on Schistosomiasis japonica

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Praziquantel in Children Under Age 4
Praziquantel - Schistosomiasis, Schistosomiasis Mansoni
Phase 2CompletedRhode Island Hospital3542021-02-012026-04-23
S. Japonicum and Pregnancy Outcomes
Praziquantel, Placebo - Schistosomiasis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3702007-08-012016-01-26

Narrower conditions

Schistosomiasis (2)  ·  Schistosomiasis mansoni (1)

Broader conditions

Helminthiasis (2)  ·  Infections (2)  ·  Parasitic Diseases (2)  ·  Trematode Infections (2)  ·  Vector Borne Diseases (2)

Interventions

Praziquantel (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Rhode Island Hospital (1)

Countries

Philippines (1)  ·  Uganda (1)  ·  United Kingdom (1)

Results publications

PMID 26511959, PMID 27441564, PMID 29546300, PMID 31188820, PMID 33861768, PMID 33998661, PMID 40412398

NIH funding

R01HD095562 (1)